Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): Implications for GDNF as a therapeutic molecule for treating neurodegenerative diseases

Cell and Tissue Research

Volumn 286, Issue 2, 1996, Pages 179-189

  Lapchak, Paul A ^a   Jiao, Shoushu ^a   Miller, Paul J ^a   Williams, Lawrence R ^a   Cummins, Vierka ^a   Inouye, Glen ^a   Matheson, Christine R ^a   Yan, Qiao ^a  

^a AMGEN INC   (United States)

Author keywords

Amytrophic lateral sclerosis; Cholinergic and noradrenergic neurons; Dementia; GDNF; Motorneurons; Neurotrophic factor; Parkinson's disease; Primate; Rodent

Indexed keywords

NEURITE PROMOTING FACTOR;

CHOLINERGIC SYSTEM; DEGENERATIVE DISEASE; FOREBRAIN; MOTONEURON; NERVE DEGENERATION; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; NERVE DEGENERATION; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS;

PRIMATES; RODENTIA;

EID: 0029804160     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004410050687     Document Type: Review

References (90)

1. Alderson RF, Wiegand SJ, Andersen KD, Cai N, Cho JY, Lindsay RM, Altar CA (1996) Neurotrophin-4/5 maintains the cholinergic phenotype of axotomized septal neurons. Eur J Neurosci 8:282-290
2. Araujo DM, Lapchak PA, Hefti F (1993) Effects of chronic basic fibroblast growth factor administration to rats with partial fimbrial transections on presynaptic cholinergic parameters and muscarinic receptors in the hippocampus: comparison with nerve growth factor. J Neurochem 61:899-910
3. Arenas E, Trupp M, Akerud P, Ibanez, CF (1995) GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15:1465-1473
4. Batchelor PE, Armstrong DM, Blaker SN, Gage FH (1989) Nerve growth factor receptor and choline acetyltransferase colocalization in neurons within the rat forebrain: response to fimbria-fornix transection. J Comp Neurol 284:187-204
5. Blum M, Weickert CS (1995) GDNF mRNA expression in normal postnatal development, aging and in weaver mutant mice. Neurobiol Aging 16:925-929
6. Bowenkamp KE, Hoffman AF, Gerhardt GA, Henry MA, Biddle PT, Hoffer BJ, Granholm ACE (1995) Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J Comp Neurol 355:479-489
7. Bowenkamp KE, David D, Lapchak PA, Henry MA, Granholm AC, Hoffer BJ, Mahalik TJ (1996) 6-Hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. Exp Brain Res (in press)
8. Collins F, Lapchak PA (1995) Morphological and functional effects of GDNF in rodents and primates. Soc Neurosci 21:493
9. Corse AM, Coccia CF, Rothstein JD, Kuncl RW (1995) GDNF provides potent neuroprotection of motor neurons against chronic glutamate toxicity. Soc Neurosci Abstr 21:544
10. Daitz HM, Powell TPS (1954) Studies of the connexions of the fornix system. J Neurol Neurosurg Psychiatry 17:75-82
11. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380:252-255
12. Gillard ER, Dang DQ, Stanley BG (1993) Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake. Brain Res 628:128-136
13. Hagg T, Manthorpe M, Vahlsing HL, Varon S (1988) Delayed treatment with nerve growth factor reverses the apparent loss of cholinergic neurons after acute brain damage. Exp Neurol 101:303-312
14. Hefti F (1986) Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 6:2155-2162
15. Hefti F, Dravid A, Hartikka J (1984) Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res 293:305-311
16. Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, Simpson LC, Moffet B, Vandlen RA, Koliatsos VE, Rosenthal A (1995) GDNF: a potent survival factor for motorneurons present in peripheral nerve and muscle. Nature 266:1062-1064
17. Hoffer BJ, Hoffman A, Bowenkamp K, Huettl P, Hudson J, Martin D, Lin LFH, Gerhardt GA (1994) Glial cell derived neurotrophic factor reversed toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett 182:107-111
18. trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF. Neuron 9:465-478
19. Hou JGG, Lin LFH, Mytilineou C (1996) Glial cell line-derived neurotrophic factors exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. J Neurochem 66:74-82
20. Hudson J, Granholm AC, Gerhardt GA, Henry MA, Hoffman A, Biddle P, Leela NS, Mackerlova L, Lile JD, Collins F, Hoffer BJ (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull 36:425-432
21. Humpel C, Hoffer B, Stromberg I, Bektesh S, Collins F, Olson L (1994) Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neuroscience 59:791-795
22. Jenner P (1995) The rationale for the use of dopamine agonists in Parkinson's disease. Neurology 45:S6-S12
23. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244
24. Kearns CM, Gash DM (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res 672:101-111
25. Knüsel B, Beck KD, Winslow JW, Rosenthal A, Burton LE, Widmer HR, Nikolics K, Hefti F (1992) Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci 12:4391-4402
26. Koliatsos VE, Clatterbuck RE, Nauta HJW, Knüsel B, Burton LE, Hefti F, Mobley WC, Price DL (1991) Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann Neurol 30:831-840
27. Koliatsos VE, Price DL, Gouras GK, Cayouette MH, Burton LE, Winslow JW (1994a) Highly selective effects of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons. J Comp Neurol 343:247-262
28. Koliatsos VE, Price WL, Pardo DA, Price DL (1994b) Ventral root avulsion: an experimental model of death of adult motor neurons. J Comp Neurol 342:35-44
29. Lams BE, Isacson O, Sofroniew MV (1988) Loss of transmitterassociated enzyme staining following axotomy does not indicate death of brainstem cholinersic neurons. Brain Res 475:401-406
30. Lapchak PA (1992) Therapeutic potential for nerve growth factor in Alzheimer's disease: insights from pharmacological studies using lesioned central cholinergic neurons. Rev Neurosci 3:109-119
31. Lapchak PA (1993) Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Exp Neurol 124:16-20
32. 3H|acetylcholine release and choline acetyltransferase activity. Neuroscience 42:639-649
33. Lapchak PA, Araujo DM, Hefti F (1992a) Neurotrophins in the CNS. Rev Neurosci 3:1-10
34. Lapchak PA, Jenden DJ, Hefti F (1992b) Pharmacological stimulation reveals NGF-induced increases of in vivo hippocampal cholinergic function measured in rats with partial fimbrial transections. Neuroscience 50:847-856
35. 125I-GDNF in the rat and primate CNS following an icv injection: correlation with the behavioral and pharmacological activities of icv administered GDNF in Parkinson's disease models. ASNT P-52
36. Leenders KL, Salmon EP, Tyrrell P, Perani D, Brooks DJ, Sager H, Jones T, Marsden D, Franchowiak RSJ (1990) The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteers and in patients with Parkinson's disease. Arch Neurol 47:1290-1298
37. Li L, Wu W, Lin LFH, Lei M, Oppenheim RW, Houenou LJ (1995) Rescue of adult motorneurons from injury-induced cell death by GDNF. Proc Natl Acad Sci USA 92:9771-9775
38. Lin L-F, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132
39. 3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy. Eur J Pharmacol 156:331-340
40. Marsden CD, Parkes JD, Quinn N (1982) Fluctuations of disability in Parkinson's disease - clinical aspects. In: Marsden CD, Fahn S (eds) Movement disorders. Butterworths, London, pp 96-122
41. Martin D, Miller G, Rosendahl M, Russell DA (1995) Potent inhibitory effects of GDNF against kainic acid mediated scizures in rats. Brain Res 683:172-178
42. Martin D, Miller G, Fischer N, Dix D, Cullen T (1996) Glial derived neurotrophic factor: the lateral cerebral ventricle is an effective site of administration for stimulation of the nigrostriatal system. Eur J Neurosci (in press)
43. Morse JK, Wiegand SJ, Anderson K, You Y, Cai N, Camahan J, Miller J, DiStefano PS, Altar CA, Lindsay RM, Alderson RF (1993) Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J Neurosci 13:4146-4156
44. Naumann T, Peterson GM, Frotscher M (1992) Fine structure of rat septohippocampal neurons. II. A time course analysis following axotomy. J Comp Neurol 325:219-242
45. Naumann T, Kenmer P, Frotscher M (1994) Fine structure of rat septohippocampal neurons. III. Recovery of choline acetyl-transferase immunoreactivity after fimbria-fornix transection. J Comp Neurol 350:161-170
46. Neff NT, Prevette D, Houenou LJ (1993) Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. J Neurobiol 24:1578-1588
47. Olson L (1994) Neurotrophins in neurodegenerative disease: theoretical issues and clinical trials. Neurochemistry 25:1-3
48. 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient. J Neural Transm 4:79-95
49. Oppenheim RW, Prevette D, Yin QW, Collins F, MacDonald J (1991) Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor. Science 251:1616-1618
50. Oppenheim RW, Yin QW, Prevette D, Yan Q (1992) Brain-derived neurotrophic factor rescues developing avian motorneurons from cell death. Nature 360:755-757
51. Oppenheim RW, Prevette D, Haverkamp LJ, Houenou L, Yin QW, McManaman J (1993) Biological studies of a putative avian muscle-derived neurotrophic factor that prevents naturally occurring motoneuron death in vivo. J Neurobiol 24:1065-1079
52. Oppenheim RW, Houenou LJ, Johnson JE, Lin LFH, Li L, Lo AC, Newsome AL, Prevette DM, Wang S (1995) Developing motor neurons rescued from programmed and axotomy-induced cell death by CDNF. Nature 363:344-346
53. Puxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, San Diego
54. Pearson RCA, Sofroniew MV, Cuello AC, Powell TPS, Eckenstein F, Esiri MM, Wilcock GK (1983) Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res 289:375-379
55. Pelleymounter MA, Williams LR (1996) Neurotrophic factors: potential for therapeutic intervention in Alzheimer's disease. In: Brioni J, Decker M (eds) Animal models of Alzheimer's disease. Wiley, New York (in press)
56. Peterson GM, Naumann T, Frotscher M (1992) Identified septohippocampal neurons survive axotomy: a fine-structural analysis in the rat. Neurosci Lett 138:81-85
57. Petty BC, Cornblath DR, Adornato BT, Chaudhry V, Flexner C, Wachsman M, Sinicropi D, Burton LE, Peroutka SJ (1994) The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 36:244-246
58. Phelps CH, Gage FH, Growdon JH, Hefti F, Harbaugh R, Johnston MV, Khachaturian ZS, Mobley WC, Price DL, Raskind M, Simpkins J, Thal LJ, Woodcock J (1989) Potential use of nerve growth factor to treat Alzheimer's disease. Neurobiol Aging 10:205-207
59. Robertson GS. Robertson HA (1988) Evidence that the substantia nigra is a site of action for L-DOPA. Neurosci Lett 89:204-208
60. Robertson GS, Robertson HA (1989) Evidence that L-DOPA-induced rotational behavior is dependent on both striatal and nigral mechanisms. J Neurosci 9:3326-3331
61. Rothstein JD, Tsai G, Kuncl RW (1990) Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 28:18-25
62. Rothstein JD, Martin LJ, Kuncl RW (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326:1464-1468
63. Rylett RJ, Williams LR (1994) Role of neurotrophins in cholinergic-neuron function in the adult and aged CNS. Trends Neurosci 17:486-490
64. Rylett RJ, Goddard S, Schmidt BM, Williams LR (1993) Acetylcholinc synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer-344 rats. J Neurosci 13:3956-3963
65. Saner H, Rosenblad C, Bjorklund A (1995) Glial cell line-derived neurotrophic factor but not transforming growth factor β3 prevents delayed degeneration of nigral neurons following striatal 6-hydroxydopamine lesions. Proc Natl Acad Sci USA 92:8935-8939
66. Scharr DG, Sieber BA, Dreyfus CF, Black I (1993) Regional and cell-specific expression of GDNF in rat brain. Exp Neurol 124:368-371
67. Schmidt-Kastner R, Tomac A, Hoffer B, Bektesh S, Rosenzweig B, Olson L (1994) Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats. Mol Brain Res 26:325-330
68. Sendtner M, Kreutzberg GW, Thoenen H (1990) Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345:440-441
69. Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde YA (1992a) Brain-derived neurotrophic factor prevents the death of motorneurons in newborn rats after nerve section. Nature 360:757-759
70. Sendtner M, Schmalbruch H, Stockli KA, Carroll P, Kreutzberg GW, Thoenen H (1992b) Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358:502-504
71. Shults CW, Shin C, Ernesto C, Martin D (1996) Hffects of intrastriatal injections of glial cell line-derived neurotrophic factor (GDNF) in rats. Exp Neurol (in press)
72. Sofroniew M, Cooper JD, Svendsen CN, Crossman P, Ip NY, Lindsay RM, Zafra F, Lindholm D (1993) Atrophy but not death of adult septal cholinergic neurons after ablation of target capacity to produce mRNAs for NGF, BDNF, and NT3. J Neurosci 13:5263-5276
73. Springer JE, Koh S, Tayrien MW, Loy R (1987) Basal forebrain magnocellular neurons stain for nerve growth factor receptor: correlation with cholinergic cell bodies and effects of axotomy. J Neurosci Res 17:111-118
74. Springer JE, Seeburger JL, He J, Gabrea A, Blankenhorn EP, Bergman LW (1995) cDNA sequence and differential mRNA regulation of two forms of glial cell line-derived neurotrophic factor in Schwann cells and rat skeletal muscle. Exp Neurol 131:47-52
75. Stromberg I, Bjorklund L, Johansson M, Tomac A, Collins F, Olson L, Hoffer BJ, Humpel C (1993) Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo, Exp Neurol 124:401-412
76. Suter-Crazzolara C, Unsicker K (1994) GDNF is expressed in two forms in many tissues outside the CNS. Neuroreport 5:2486-2488
77. Thoenen H, Hughes RA, Sendtner M (1993) Trophic support of motorneurons: physiological, pathophysiological, and therapeutic implications. Exp Neurol 124:47-55
78. Tomac A, Widenfalk J, Lin LFH, Kohno T, Ebendal T, Hoffer BJ, Olson L (1995) Retrograde axonal transport of GDNF in the adult nigrostriatal system suggests a trophic role in the adult. Proc Natl Acad Sci USA 92:8274-8278
79. Trupp M, Ryden M, Jornvall H, Funakoshi H, Timmusk T, Arenas E, Ibanez CF (1995) Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol 130:137-148
80. Tuszynski MH, Armstrong DM, Gage FH (1990) Basal forebrain cell loss following fimbria/fornix transection. Brain Res 508:241-248
81. Wang X, Tien LT, Lapchak PA, Hoffer BJ (1996) GDNF triggers fiber outgrowth of fetal ventral mesenencephalic grafts from nigra to striatum in 6-OHDA lesioned rats. Cell Tissue Res (in press)
82. Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, Björklund A, Gage FH (1986) Continuous infusion and nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci USA 83:9231-9235
83. Williams LR, Jodelis KS, Donald MR (1989) Axotomy-dependent stimulation of choline acetyltransferase by exogenous mouse nerve growth factor in rat basal forebrain. Brain Res 498:243-256
84. Williams LR, Inouye G, Cummins V, Pelleymounter MA (1996) GDNF sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to NGF and BDNF. J Pharmacol Exp Ther 277:1140-1151
85. Wu W (1993) Expression of nitric-oxide synthase (NOS) in injured CNS neurons as shown by NADPH diaphorase histochemistry. Exp Neurol 120:153-159
86. Van Q, Matheson CR (1995) Retrograde transport study of glial cell line-derived neurotrophic factor (GDNF) in adult rat nervous system. Soc Neurosci Abstr 21:1301
87. Van Q, Elliott J, Snider WD (1992) Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 360:753-755
88. Van Q, Elliott JL, Matheson C, Sun J, Zhung L, Mu A, Rex KL, Snider WD (1993) Influences of neurotrophins on mammalian motorneurons in vivo. J Neurobiol 24:1555-1577
89. Van Q, Matheson C, Lopez OT, Miller JA (1994) The biological responses of axotomized adult motorneurons to brain-derived neurotrophic factor. J Neurosci 14:5281-5291
90. Van Q, Matheson C, Lopez OT (1995) In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373:341-344